AMPLIFY™ Technology Enhances Prenatal Screening for 22q11.2 Microdeletion
Myriad Genetics
APRIL 15, 2024
Typically, the way to diagnose 22q prenatally is through chorionic villus sampling or an amniocentesis. 4 In a recent presentation, Dale Muzzey, PhD, Chief Scientific Officer at Myriad, summarized the findings this way: “We followed up with providers regarding their patients who screened positive for 22q. Genet Med   3 , 14–18 (2001).
52 
Let's personalize your content